Insulin

There are 1,881 papers on insulin in aging research: 648 trials and 422 observational studies in people, 458 in animals, 20 in cells, 298 reviews.

Biomarker

1,881 papers study it10,187 more mention it312 findings

MeSH

714 new papers in 30 daysSee all 12,068 papers on insulin

At a glance

Insulin is linked with higher mortality in a human cohort and with cellular senescence in human liver. Human trials report lower insulin with exercise and caloric restriction, while a five-day trial in people with newly detected type 2 diabetes shows no clear effect of metformin or creatine on insulin.

312 findings in 269 papers from 1984 to 2026, 26 of them since April 2026

“After Diet P, only subjects with GG genotype showed a significant improvement in the insulin levels”
Single nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 interact with different type of dietary fatty acids in two hypocaloric dietsEuropean review for medical and pharmacological sciences2019doi:10.26355/eurrev_201904_17577
  • Human trial648
  • Humans422
  • Animals457
  • Model organisms1
  • Cells20
  • In silico9

Interventions

133

Caloric restriction

downin humans6downin mice5downin Mammalia1upin mice1+1−80%

14 studies
  1. Caloric restriction decreases insulin in humans.

    “When repeated measurements were compared, insulin levels were found to be significantly decreased in all obese groups.”

    Human trial12-weekfemalesn = 54

    Effects of Long-Term Calorie Restriction and Physical Activity on Body Weight and Metabolism Applied to Different Degrees of Obesity

    The Eurasian journal of medicine

  2. Caloric restriction decreases insulin in humans (P < .05).

    “insulin levels in all obese groups decreased significantly (P < .05).”

    Human trial12 weeksfemalesn = 54

    Effects of Long-Term Calorie Restriction and Physical Activity on Body Weight and Metabolism Applied to Different Degrees of Obesity

    The Eurasian journal of medicine

  3. Caloric restriction decreases insulin in humans (randomized to CR vs no CR) (mean difference -15.3 pmol/mL (95% CI -8.1, -22.6)).

    “CR was associated with significant improvements in CRP and insulin compared to no CR”

    Human trialrandomized to CR vs no CR6 months

    Caloric Restriction and Changes in Geroscience Blood-Based Biomarkers in Older Adults

    GSA 2025 abstract

  4. Caloric restriction decreases insulin in T2D patients.

    “CR lowered insulin in T2D patients, whereas glucose, GIP, and GLP-1 were unaffected.”

    Human trialin T2D patients

    Roux-en-Y gastric bypass versus calorie restriction: support for surgery per se as the direct contributor to altered responses of insulin and incretins to a mixed meal

    Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery

  5. Caloric restriction decreases insulin in humans (-34% to -38%).

    “Following both low energy availability conditions, leptin (-53% to -56%) and insulin (-34% to -38%) were reduced (P < 0.05).”

    Human trial15 kcal · kg(-1) fat-free mass [FFM] · day(-1)4-daymalesn = 6

    Low energy availability in exercising men is associated with reduced leptin and insulin but not with changes in other metabolic hormones

    Journal of sports sciences

  6. Caloric restriction decreases insulin in humans (compared with fed state).

    “Mean glucose, insulin, and leptin concentrations were lower (P < 0.0001) for CAL-DEP compared to the fully fed (FED) state.”

    Human trialcompared with fed state<10% of estimated energy requirements48 h

    Appetite and endocrine regulators of energy balance after 2 days of energy restriction: insulin, leptin, ghrelin, and DHEA-S

    Obesity (Silver Spring, Md.)

  7. Caloric restriction decreases insulin in mice.

    “CR decreased basal insulin concentrations in all age groups”

    Animals15%males

    Metabolic and physical function are improved with lifelong 15% calorie restriction in aging male mice

    Biogerontology

  8. Caloric restriction increases insulin in TejJ89 and TejJ114 relative to AL controls.

    “both strains TejJ89 and TejJ114 were hyperinsulinemic following CR relative to their AL controls.”

    Animalsin TejJ89 and TejJ114 relative to AL controls10 monthsfemales

    Strain-specific metabolic responses to long-term caloric restriction in female ILSXISS recombinant inbred mice

    Molecular and cellular endocrinology

  9. Caloric restriction decreases insulin in high-fat diet and renal artery stenosis rats (OHR group).

    “Reductions in insulinemia, lipids, islets fibrotic areas in the OHR group were observed along with increased insulin sensitivity”

    Animalsin high-fat diet and renal artery stenosis rats (OHR group)

    Caloric restriction overcomes pre-diabetic and hypertension induced by high fat diet and renal artery stenosis

    bioRxiv (Cold Spring Harbor Laboratory)Preprint

  10. Caloric restriction decreases insulin in mice (CR mice compared with AL-control).

    “CR-mice showed lowered cholesterol, insulin and leptin levels”

    AnimalsCR mice compared with AL-control

    Resveratrol, lunularin and dihydroresveratrol do not act as caloric restriction mimetics when administered intraperitoneally in mice

    Scientific reports

All 15

More on Caloric restriction

Exercise

downin humans12−40% lower

12 studies
  1. Exercise prevents insulin in humans.

    “There was a significantly greater increase in insulin in the control group compared to the exercise group (p = 0.034), while no significant differences were found for glucose, IGF-1, or IGFBP-1.”

    Human trial12-weekfemales

    Exploring the feasibility of exercise training during (neo)adjuvant chemotherapy in women with early-stage breast cancer: a pilot study examining immune and metabolic outcomes

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

  2. Exercise prevents insulin in humans during (neo)adjuvant chemotherapy (p = 0.034).

    “Exercise prevented the insulin rise observed in controls (p = 0.034).”

    Human trialduring (neo)adjuvant chemotherapy12-weekfemales

    Exploring the feasibility of exercise training during (neo)adjuvant chemotherapy in women with early-stage breast cancer: a pilot study examining immune and metabolic outcomes

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

  3. Exercise decreases insulin in humans during oral glucose tolerance test.

    “Exercise had no effect on glucose following INI, although insulin was reduced during the OGTT (P < 0.05).”

    Human trialduring oral glucose tolerance test

    Acute exercise reduces intranasal insulin-mediated elevations in blood pressure in aging adults with cardiometabolic risk

    American journal of physiology. Regulatory, integrative and comparative physiology

  4. Exercise decreases insulin in humans.

    “In addition, insulin was significantly lower after exercise compared with rest during the OGTT (p = 0.004) and the entire protocol (p = 0.007).”

    Human trial60 minn = 15

    Appetite Perception and Cerebral Blood Flow in Aging Adults Following a Single Bout of Exercise

    Nutrients

  5. Exercise decreases insulin in humans (p = 0.007).

    “Exercise tended to lower blood glucose (p = 0.072) and plasma insulin (p = 0.007) tAUC, compared with rest.”

    Human trialacute exercise (70% maximal oxygen consumption)n = 15

    Appetite Perception and Cerebral Blood Flow in Aging Adults Following a Single Bout of Exercise

    Nutrients

  6. Exercise decreases insulin in humans.

    “Venous glucose, insulin, and HOMA‐IR were lower after exercise relative to the rest condition (p < 0.001, all); however, there were no differences found for venous lactate concentration between rest and exercise conditions (p = 0.27).”

    Human trial2 weeksn = 36

    Postprandial exercise attenuates glucose and insulin and is associated with age, cognitive function, and extracellular/intracellular body water

    Physiological reports

  7. Exercise decreases insulin in humans (p < 0.001).

    “Postprandial exercise decreased insulin and glucose in younger and older adults compared to postprandial sitting (p < 0.001, p = 0.003).”

    Human trialn = 36

    Postprandial exercise attenuates glucose and insulin and is associated with age, cognitive function, and extracellular/intracellular body water

    Physiological reports

  8. Exercise is linked with lower insulin in humans (compared with untrained middle-aged adults) (p < 0.05).

    “UMA exhibited higher concentrations of leptin, insulin, and resistin”

    Humanscompared with untrained middle-aged adultsserummales

    Comparative adipokine profile in middle-aged master athletes, untrained adults, and young individuals

    European journal of applied physiology

  9. Exercise is linked with lower insulin in humans (active versus sedentary participants, independent of age) (40% lower).

    “Active participants had 40% lower insulin concentration and 53% lower FGF21 concentration than sedentary participants”

    Humansactive versus sedentary participants, independent of age

    Fibroblast Growth Factor 21 Mediates the Associations between Exercise, Aging, and Glucose Regulation

    Medicine and science in sports and exercise

  10. Exercise decreases insulin in humans (high-frequency interruption strategies).

    “High-frequency interruption strategies showed the most favourable acute effects on glucose and insulin responses”

    Reviewhigh-frequency interruption strategiesn = 1,369

    Effects of different sedentary interruption strategies on blood glucose, insulin, and triglycerides: A network meta-analysis

    Journal of sports sciences

All 15

More on Exercise

Resveratrol

downin humans3no changein humans1downin mice1

5 studies
  1. Resveratrol decreases insulin in humans (type 2 diabetes mellitus) (-0.97±1.91, μIU/mL, p=0.02).

    “Moreover, the mean difference in insulin levels reached significance (-0.97±1.91, μIU/mL, p= 0.02).”

    Human trialtype 2 diabetes mellitusmicronized trans-resveratrol1000 mg/day8 weeksn = 71

    The Effect of Resveratrol Supplementation on Cardio-Metabolic Risk Factors in Patients with Type 2 Diabetes: A Randomized, Double-Blind Controlled Trial

    Phytotherapy research : PTR

  2. Resveratrol decreases insulin in humans (patients with type 2 diabetes with sample size ≥ 500 and study number ≥ 10).

    “significant decline in serum insulin level was observed for sample size ≥ 500 and study number ≥ 10.”

    Reviewpatients with type 2 diabetes with sample size ≥ 500 and study number ≥ 10

    The effects of resveratrol on glycemic indices and lipid profile in patients with type 2 diabetes: an umbrella review and meta-analysis

    Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences

  3. Resveratrol showed no clear effect on insulin in individuals with obesity or overweight (SMD = -0.00, 95%CI [-0.25, 0.24], P = 0.97).

    “Similarly, no significant effect was observed for insulin levels (SMD = -0.00, 95%CI [-0.25, 0.24], P = 0.97, I2 = 0 %)”

    Reviewin individuals with obesity or overweight4-week

    Effect of resveratrol supplementation on metabolic risk markers and anthropometric parameters in individuals with obesity or overweight: A systematic review and meta-analysis of randomized controlled trials

    Obesity pillars

  4. Resveratrol decreases insulin in mice (high-fat diet-fed mice).

    “lowered fasting and post-glucose-bolus insulin levels”

    Animalshigh-fat diet-fed mice≈28 mg (dihydro)stilbene kg−1 mouse per day

    The Putative Caloric Restriction Mimetic Resveratrol has Moderate Impact on Insulin Sensitivity, Body Composition, and the Metabolome in Mice

    Molecular nutrition & food research

  5. Resveratrol decreases insulin in T2DM participants (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001).

    “and insulin levels (-0.64 U/mL, 95% CI: -0.95, -0.32, p < 0.0001).”

    Reviewin T2DM participants

    Effects of resveratrol on glucose control and insulin sensitivity in subjects with type 2 diabetes: systematic review and meta-analysis

    Nutrition & metabolism

More on Resveratrol

Dehydroepiandrosterone

no changein humans2downin humans1upin humans1downin mice1+50%

5 studies
  1. Dehydroepiandrosterone decreases insulin in humans (hypoadrenal women) (42 +/- 4.94 vs. 53 +/- 6.58 pmol/l [P = 0.005]).

    “Fasting plasma insulin and glucagon were lower with DHEA (42 +/- 4.94 vs. 53 +/- 6.58 pmol/l [P = 0.005]”

    Human trialhypoadrenal women50-mg12 weeksfemalesn = 28

    Effect of dehydroepiandrosterone replacement on insulin sensitivity and lipids in hypoadrenal women

    Diabetes

  2. Dehydroepiandrosterone showed no clear effect on insulin in humans (hypercholesterolemia).

    “In contrast, steady state plasma insulin did not change during the study in either group.”

    Human trialhypercholesterolemia25 mg/d12 wkmalesn = 24

    Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men

    The Journal of clinical endocrinology and metabolism

  3. Dehydroepiandrosterone increases insulin in humans (+50%).

    “were accompanied by a 50% increase in the integrated insulin response (P less than 0.01) without a significant change in fasting glucose insulin or glucose-6-phosphate dehydrogenase values.”

    Human trialoral1600 mg/day28 daysfemalesn = 6

    The effects of oral dehydroepiandrosterone on endocrine-metabolic parameters in postmenopausal women

    The Journal of clinical endocrinology and metabolism

  4. Dehydroepiandrosterone showed no clear effect on insulin in humans (WMD: 0.057 μU/mL, P = 0.067).

    “DHEA administration did not result in any significant changes in IN (WMD: 0.057 μU/mL, P = 0.067)”

    Review

    The influence of dehydroepiandrosterone (DHEA) on fasting plasma glucose, insulin levels and insulin resistance (HOMA-IR) index: A systematic review and dose response meta-analysis of randomized controlled trials

    Complementary therapies in medicine

  5. Dehydroepiandrosterone decreases insulin in mice (normal BL/6 mice).

    “Four weeks of DHEA treatment initiated at 2 yr of age improved glucose tolerance and at the same time reduced plasma insulin to a "younger" level.”

    Animalsnormal BL/6 miceplasma4 weeksfemales

    Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice

    Diabetes

More on Dehydroepiandrosterone

Fasting

downin humans3upin human cells1

4 studies
  1. Fasting decreases insulin in obese PCOS and obese control women.

    “Insulin and leptin significantly decreased, while insulin sensitivity significantly improved in both groups during fasting.”

    Human trialin obese PCOS and obese control women3 daysfemales

    Growth-hormone response to combined stimulation with GHRH plus GH-releasing peptide-6 in obese patients with polycystic ovary syndrome before and after short-term fasting

    Journal of endocrinological investigation

  2. Fasting decreases insulin in humans (obesity).

    “During starvation insulinaemia is declining”

    Human trialobesityblood2 weeksn = 11

    Dehydroepiandrosterone and insulinaemia

    Sbornik lekarsky

  3. Fasting decreases insulin in humans.

    “The GH increase was associated with decreased insulin and leptin, stimulating lipolysis.”

    Review24-48hn = 119

    Effect of 24 to 48 hours of fasting on growth hormone levels in healthy adults: a systematic review

    SciELO PreprintsPreprint

  4. Fasting induces insulin in human type 1 diabetes pancreatic islets.

    “fasting conditions reduce PKA and mTOR activity and induce Sox2 and Ngn3 expression and insulin production”

    Cellsin human type 1 diabetes pancreatic isletspancreatic islet

    Fasting-Mimicking Diet Promotes Ngn3-Driven β-Cell Regeneration to Reverse Diabetes

    Cell

More on Fasting

High-intensity interval training

downin humans2upin humans1downin mice1

4 studies
  1. High-intensity interval training increases insulin in humans (overweight postmenopausal women) (p < 0.01).

    “Significant within-group increases in irisin (p < 0.01), insulin (p < 0.01), and glucose (p < 0.05) were observed following HIIT.”

    Human trialoverweight postmenopausal women20 minfemalesn = 28

    The impact of acute morning versus evening high-intensity interval training on circulating irisin levels and metabolic parameters in overweight postmenopausal women

    Experimental gerontology

  2. High-intensity interval training decreases insulin in humans (15.8 ± 8.1 to 14.0 ± 7.8 uIU/ml).

    “HIIT induced a small decrease in SED insulin compared to baseline (15.8 ± 8.1 uIU·ml−1 at baseline and 14.0 ± 7.8 uIU·ml−1 post-HIIT; Cohen's d = 0.23)”

    Human trial6 weeksmalesn = 22

    High intensity interval training (HIIT) produces small improvements in fasting glucose, insulin, and insulin resistance in sedentary older men but not masters athletes

    Experimental gerontology

  3. High-intensity interval training decreases insulin in the two-hit mouse model of HFpEF.

    “Furthermore, HIIT reduced insulin levels without affecting renal function but decreased markers of kidney damage.”

    Animalsin the two-hit mouse model of HFpEF5 weeksmales

    High-intensity interval training attenuates the progression of diastolic and skeletal muscle dysfunction in the two-hit mouse model of HFpEF

    Life sciences

  4. High-intensity interval training decreases insulin in women with polycystic ovary syndrome (MD -1.88, 95% CI -2.70 to -1.07).

    “HIIT significantly improved insulin levels (MD = −1.88, 95% CI: −2.70 to −1.07, p < 0.001)”

    Reviewin women with polycystic ovary syndrome

    MON-148 Comparative Metabolic Effects Of High, Moderate, And Low-intensity Exercise In Polycystic Ovary Syndrome: A Systematic Review And Network Meta-analysis Of Randomized Controlled Trials

    ENDO 2025 abstract

More on High-intensity interval training

Melatonin

downin humans2no changein humans2

4 studies
  1. Melatonin showed no clear effect on insulin in humans.

    “No significant changes were observed for leptin, insulin or markers of glucose homeostasis.”

    Human trial1 or 3 mg nightly1 yearfemalesn = 81

    Reduced fat mass and increased lean mass in response to 1 year of melatonin treatment in postmenopausal women: A randomized placebo-controlled trial

    Clinical endocrinology

  2. Melatonin decreases insulin in humans (supplementation in adults) (WMD = -1.58 μIU/ml, 95%CI: -2.40 to -0.76).

    “insulin (WMD = -1.58 μIU/ml, 95%CI: -2.40 to -0.76, n = 16)”

    Reviewsupplementation in adults

    Effects of melatonin supplementation on blood glycemic indices in adults: a GRADE-assessed systematic review and dose-response meta-analysis of randomized controlled trials

    Nutrition & metabolism

  3. Melatonin decreases insulin in humans.

    “melatonin administration significantly reduced insulin levels”

    Review

    Effects of Melatonin Supplementation on Insulin Levels and Insulin Resistance: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

  4. Melatonin showed no clear effect on insulin in humans (SMD=-1.03; 95% CI, -3.82, 1.77; p=0.47).

    “melatonin administration did not significantly influence insulin levels (SMD=-1.03; 95% CI, -3.82, 1.77; p=0.47; I2: 0.53)”

    Review

    The Effects of Melatonin Supplementation on Glycemic Control: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

More on Melatonin

Intermittent fasting

downin humans2downin mice1downin rats1

4 studies
  1. Intermittent fasting decreases insulin in cancer patients undergoing chemotherapy and/or targeted therapies.

    “a consistent trend emerged in reduced insulin and IGF-1 levels”

    Reviewin cancer patients undergoing chemotherapy and/or targeted therapies

    Impact of intermittent fasting on patients with cancer undergoing chemotherapy and/or targeted therapies: a systematic review of the literature

    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

  2. Intermittent fasting decreases insulin in gynecological and breast cancer patients (SMD -0.395 mU/L, 95% CI -0.674 to -0.116, p = 0.005).

    “and insulin concentrations (SMD: -0.395 mU/L; 95% CI: -0.674 to -0.116; p = 0.005).”

    Reviewin gynecological and breast cancer patients

    The effects of intermittent fasting on anthropometric indices, glycemic profile, chemotherapy-related toxicity, and subjective perception in gynecological and breast cancer patients: a systematic review and meta-analysis

    BMC cancer

  3. Intermittent fasting decreases insulin in old rats.

    “EOD decreased insulin level (p < 0.05 vs. AL) in old animals”

    Animalsin old ratsfasting every other day3 monthsmales

    The Effects of Age and Fasting Models on Blood Pressure, Insulin/Glucose Profile, and Expression of Longevity Proteins in Male Rats

    Rejuvenation research

  4. Intermittent fasting decreases insulin in mice.

    “reduced serum glucose and insulin levels”

    Animals

    Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake

    Proceedings of the National Academy of Sciences of the United States of America

More on Intermittent fasting

Acarbose

downin humans2upin humans1no changein humans1

4 studies
  1. Acarbose improves insulin in humans (overweight patients compared with nonoverweight patients).

    “Acarbose has been found to improve insulin levels and thus glucose/insulin ratios more effectively in overweight patients compared with nonoverweight patients with PCOS.”

    Human trialoverweight patients compared with nonoverweight patientsfemalesn = 74

    Clinical, endocrine, and metabolic effects of acarbose, a alpha-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome

    Fertility and sterility

  2. Acarbose decreases insulin in humans (Postprandial hypotension with autonomic failure; compared with placebo) (Reduction of 11 microU/mL (95% CI 5 to 18; P=0.001)).

    “acarbose effectively reduced plasma levels of insulin, a known vasodilator, by 11 microU/mL (95% CI: 5 to 18; P=0.001) compared with placebo.”

    Human trialPostprandial hypotension with autonomic failure; compared with placeboplasma100 mg90 minutes after meal intaken = 13

    Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure

    Hypertension (Dallas, Tex. : 1979)

  3. Acarbose decreases insulin in meals containing carbohydrates.

    “acarbose attenuated responses of plasma insulin and glucose-dependent insulinotropic polypeptide (GIP)”

    Human trialin meals containing carbohydrates100 mg

    Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release

    American journal of physiology. Gastrointestinal and liver physiology

  4. Acarbose showed no clear effect on insulin in humans (type 2 diabetes; postprandial measurement).

    “Postprandial insulin or triglyceride levels were not significantly altered with single dose acarbose treatment.”

    Human trialtype 2 diabetes; postprandial measurementsingle dosen = 14

    Dose-response profile of acarbose in older subjects with type 2 diabetes

    The American journal of the medical sciences

More on Acarbose

Vitamin D

downin humans3

3 studies
  1. Vitamin D decreases insulin in humans (MD = −0.30; 95% CI –0.56 to −0.03).

    “In terms of decreasing fasting insulin (FIN) level, EHDS (mean difference [MD] = −0.30; 95% CI –0.56 to −0.03) was more effective than control.”

    Human trial

    Effects of Vitamin D Supplemental Dose in Adults with Prediabetes: A Systematic Review and Network Meta-Analysis

    Nutrition reviews

  2. Vitamin D decreases insulin in humans (prediabetes) (MD = -0.30, 95% CI -0.56 to -0.03).

    “In terms of decreasing fasting insulin (FIN) level, EHDS (mean difference [MD] = -0.30; 95% CI -0.56 to -0.03) was more effective than control.”

    Human trialprediabetes≥4000 IU d-1

    Effects of Vitamin D Supplemental Dose in Adults with Prediabetes: A Systematic Review and Network Meta-Analysis

    Nutrition reviews

  3. Vitamin D decreases insulin in humans (polycystic ovary syndrome) (MD -1.98 μIU/mL, 95% CI (-3.32, -0.64) μIU/mL).

    “insulin levels[MD=-1.98 μIU/mL, 95% CI (-3.32, -0.64) μIU/mL, P = 0.004]”

    Reviewpolycystic ovary syndrome

    The impact of vitamin D supplementation on glycemic control and lipid metabolism in polycystic ovary syndrome: a systematic review of randomized controlled trials

    BMC endocrine disorders

  4. Vitamin D decreases insulin in humans.

    “Furthermore, short-term intervention (≤ 6 months) induced a significantly lower level of TG and insulin in comparison to longer duration (> 6 months).”

    Review≤ 6 months

    Effect of vitamin D supplementation on cardiac-metabolic risk factors in elderly: a systematic review and meta-analysis of clinical trials

    Diabetology & metabolic syndrome

More on Vitamin D

Combined aerobic and resistance training

downin humans3

3 studies
  1. Combined aerobic and resistance training prevents insulin in humans.

    “Exercise prevented the insulin rise observed in controls (p = 0.034).”

    Human trial12 weeksfemales

    Exploring the feasibility of exercise training during (neo)adjuvant chemotherapy in women with early- stage breast cancer: a pilot study examining immune and metabolic outcomes

    Research SquarePreprint

  2. Combined aerobic and resistance training prevents insulin in humans during (neo)adjuvant chemotherapy (p = 0.034).

    “Exercise prevented the insulin rise observed in controls (p = 0.034).”

    Human trialduring (neo)adjuvant chemotherapy12-weekfemales

    Exploring the feasibility of exercise training during (neo)adjuvant chemotherapy in women with early- stage breast cancer: a pilot study examining immune and metabolic outcomes

    Research SquarePreprint

  3. Combined aerobic and resistance training decreases insulin in humans (stage I sarcopenic obesity) (MD = -1.73, p < 0.05).

    “Additionally, CE lowered insulin (MD = -1.73, p < 0.05)”

    Reviewstage I sarcopenic obesity≥8-week

    Exercise interventions of ≥8 weeks improve body composition, physical function, metabolism, and inflammation in older adults with stage I sarcopenic obesity: a systematic review and meta-analysis

    Frontiers in nutrition

  4. Combined aerobic and resistance training decreases insulin in humans (compared with usual care) (P = .002).

    “circulating biomarkers, including insulin ( P = .002), IGF-1 ( P = .001), leptin ( P = .001), and adiponectin ( P = .001), were significantly improved postintervention compared with usual care.”

    Reviewcompared with usual carethree times per week, 65% to 85% of heart rate maximum16 weeksn = 100

    Effects of Aerobic and Resistance Exercise on Metabolic Syndrome, Sarcopenic Obesity, and Circulating Biomarkers in Overweight or Obese Survivors of Breast Cancer: A Randomized Controlled Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology

More on Combined aerobic and resistance training

Curcumin

downin humans2upin humans1

3 studies
  1. Curcumin decreases insulin in overweight/obese women with polycystic ovary syndrome (p = 0.020).

    “Serum insulin (p = 0.020) and Quantitative Insulin Sensitivity Check Index (QUICKI) (p = 0.003) were improved significantly”

    Human trialin overweight/obese women with polycystic ovary syndrome500 mg/d twice daily6 weeksfemalesn = 60

    The effects of curcumin supplementation on glycemic status, lipid profile and hs-CRP levels in overweight/obese women with polycystic ovary syndrome: A randomized, double-blind, placebo-controlled clinical trial

    Complementary therapies in medicine

  2. Curcumin decreases insulin in humans (-26.5%, P = 0.01).

    “Pairwise analysis shown mean change in AUC values for insulin was significantly lower only with curcumin (26.5%, P = 0.01) and curcumin + fish oil treatments (25.8%, P = 0.03) but not with fish oil treatment (18%, P = 0.140), when compared with placebo.”

    Human trial2 hn = 16

    Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study

    Scientific reports

  3. Curcumin decreases insulin in humans (-26%, P = 0.01).

    “Both curcumin (P = 0.01) and curcumin + fishoil (P = 0.03) treatments significantly lowered postprandial insulin (AUC) by 26% in comparison with placebo.”

    Human trialtablets120 minn = 16

    Curcumin alleviates postprandial glycaemic response in healthy subjects: A cross-over, randomized controlled study

    Scientific reports

  4. Curcumin increases insulin in humans (patients with metabolic syndrome and related disorders) (SMD 0.92; 95% CI, 0.06, 1.78; P=0.036).

    “curcumin intake significantly increased insulin levels (SMD 0.92; 95% CI, 0.06, 1.78; P=0.036).”

    Reviewpatients with metabolic syndrome and related disordersn = 1,890

    The Effects of Curcumin on Glycemic Control and Lipid Profiles Among Patients with Metabolic Syndrome and Related Disorders: A Systematic Review and Metaanalysis of Randomized Controlled Trials

    Current pharmaceutical design

More on Curcumin

Walking

no changein humans2downin humans1

3 studies
  1. Walking decreases insulin in humans (compared with uninterrupted sitting (50SW and 30SW protocols)) (-20.1% (50SW), -18.2% (30SW)).

    “insulin tAUC was reduced by 20.1% and 18.2%, respectively (p < .001).”

    Human trialcompared with uninterrupted sitting (50SW and 30SW protocols)40-50% HRmax300-minmalesn = 16

    Effects of breaking up prolonged sitting with light-intensity walking on postprandial glucose and lipid responses in sedentary adult men

    Journal of sports sciences

  2. Walking showed no clear effect on insulin in humans.

    “whereas no difference was observed for insulin”

    Human trialplasma-serum8 hoursn = 12

    Acute metabolic responses to breaking up sedentary time in older adults

    Physiology & behavior

  3. Walking showed no clear effect on insulin in humans (low-risk, localized PCa) (p > 0.05).

    “Analyses showed no changes within or differences in changes between intervention and control groups from baseline to 16 weeks for any biomarker (p > 0.05).”

    Human triallow-risk, localized PCa16 weeksmales

    Inflammation and insulin profiles in men assigned to exercise vs. usual care for prostate cancer: results from the active surveillance exercise (ASX) randomized controlled trial

    Cancer causes & control : CCC

More on Walking

Metformin

downin mice2no changein humans1

3 studies
  1. Metformin showed no clear effect on insulin in humans (recently detected type II diabetics).

    “Neither treatment altered insulin, c-peptide, or HbA1c.”

    Human trialrecently detected type II diabetics5 days

    Comparison of antihyperglycemic effects of creatine and metformin in type II diabetic patients

    Clinical and investigative medicine. Medecine clinique et experimentale

  2. Metformin decreases insulin in high-fat diet-induced obese FVB/N mice.

    “only a decrease in insulin was observed in metformin-treated HFD mice.”

    Animalsin high-fat diet-induced obese FVB/N miceoral250 mg/kg/day

    Metformin improves hepatic steatosis in diet induced obese FVB/N mice: Alterations of glucose metabolism and hepatic splicing machinery

    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

  3. Metformin decreases insulin in mice.

    “Metformin treatment reduced circulating insulin levels in fasting and non-fasting conditions for male mice”

    Animalsmales

    Metformin treatment of juvenile mice alters aging-related developmental and metabolic phenotypes in sex-dependent and sex-independent manners

    GeroScience

More on Metformin

Ketogenic diet

downin humans3

3 studies
  1. Ketogenic diet decreases insulin in humans (at -5% weight loss).

    “VLCKD showed greater reductions in insulin at -5% wt loss (-23% vs -0%, p<0,001)”

    Human trialat -5% weight loss

    Effects of a Very-Low-Calories Ketogenic Diet on Visceral Adipose and Muscular Tissues in Comparison with a Mediterranean Dietary Intervention

    ADA Scientific Sessions 2025 abstract

  2. Ketogenic diet decreases insulin in humans (MD: -2.57 mU/L [95 % CI -4.41 to -0.74], p=0.006).

    “KDs were also associated with significantly decreased fasting insulin (MD: -2.57 mU/L [95 % CI -4.41 to -0.74], p=0.006)”

    Review1 to 20 weeks

    Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: A systematic review and meta-analysis

    Ageing research reviews

  3. Ketogenic diet decreases insulin in patients with metastatic cancer.

    “These approaches have also been shown to improve serum insulin and other metabolic parameters.”

    Reviewin patients with metastatic cancer

    Insulin-Lowering Diets in Metastatic Cancer

    Nutrients

More on Ketogenic diet

All 133

Effects

3

PhenoAgeAccel

mediatesin humans1

1 study
  1. Insulin is linked with PhenoAgeAccel in humans (part of the association between behavioral rhythm scores and PhenoAgeAccel).

    “Serum 25(OH)D3 and insulin each significantly mediated part of the association (both P < 0.05).”

    Humanspart of the association between behavioral rhythm scores and PhenoAgeAcceln = 4,702

    Behavioral Rhythms and Biological Age Acceleration: Potential Mediating Roles of Serum 25-Hydroxyvitamin D3 and Insulin

    Research SquarePreprint

More on PhenoAgeAccel

Alzheimer's disease

no changein humans1

1 study
  1. Insulin was not clearly linked with Alzheimer's disease in humans (adjusted regression analyses).

    “Serum insulin and related measures were not associated with the level of Alzheimer's disease pathology”

    Humansadjusted regression analyses

    Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes

    Annals of neurology

More on Alzheimer's disease

Cognitive function

mediatesin humans1

1 study
  1. Insulin is linked with cognitive function in humans (mild cognitive impairment).

    “lower insulin levels established complete mediation between IF practice and better cognitive function”

    Humansmild cognitive impairment36 monthsn = 99

    Antioxidant Potential, DNA Damage, Inflammation, Glycemic Control and Lipid Metabolism Alteration: A Mediation Analysis of Islamic Sunnah Intermittent Fasting on Cognitive Function among Older Adults with Mild Cognitive Impairment

    The journal of nutrition, health & aging

Upstream

10

Type 2 diabetes

upin humans1downin rats1

2 studies
  1. Type 2 diabetes is linked with higher insulin in DM patients compared with normoglycemic controls.

    “All DM patients showed elevated insulin levels than normoglycemic controls.”

    Humansin DM patients compared with normoglycemic controlsplasma

    Plasma Insulin/Erythrocytic Aldose Reductase Ratio as a Predictor for Hepatocellular Carcinoma among Type II Diabetics and Hepatitis C Virus-infected Patients

    Asian Pacific journal of cancer prevention : APJCP

  2. Type 2 diabetes decreases insulin in rats (spontaneous type 2 diabetes model).

    “Consequently, plasma insulin levels showed a significant decrease, while plasma glucose, cholesterol and triglyceride levels were increased.”

    Animalsspontaneous type 2 diabetes modelmales

    Progressive histopathological changes and β-cell loss in the pancreas of a new spontaneous rat model of type 2 diabetes

    Tissue & cell

More on Type 2 diabetes

GHR

upin mice2

2 studies
  1. GHR increases insulin in mice (shown by adipocyte-specific knockout).

    “reduced circulating levels of insulin, c-peptide, adiponectin, resistin”

    Animalsshown by adipocyte-specific knockoutplasma

    Disruption of Growth Hormone Receptor in Adipocytes Improves Insulin Sensitivity and Lifespan in Mice

    Endocrinology

  2. GHR increases insulin in mice (shown by knockout (GHR -/-)).

    “fasting insulin and glucose levels were reduced in the GHR -/- mice but normal in the GHA mice”

    Animalsshown by knockout (GHR -/-)

    Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span

    Endocrinology

More on GHR

DNA damage response

downin human cells1

1 study
  1. DNA damage response decreases insulin in human cells (growth-arrested EndoC-betaH5 beta cells).

    “DNA damage led to decreased levels of CPE and proSAAS, and reduced levels of insulin”

    Cellsgrowth-arrested EndoC-betaH5 beta cells

    Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells

    Diabetologia

More on DNA damage response

CMAH

upin mice1

1 study
  1. CMAH increases insulin in mice (shown by knockout, after oral glucose administration) (P < 0.001).

    “Unlike glucose, the insulin concentration after oral glucose administration was significantly lower in the Cmah KO group than in the WT group (P < 0.001).”

    Animalsshown by knockout, after oral glucose administration

    Cmah deficiency blunts cellular senescence in adipose tissues and improves whole-body glucose metabolism in aged mice

    Geriatrics & gerontology international

More on CMAH

FGF21

upin mice1

1 study
  1. FGF21 increases insulin in mice (shown by liver-specific knockout in ovariectomized mice).

    “Mechanically, we found that FGF21 LKO reduced circulating insulin levels”

    Animalsshown by liver-specific knockout in ovariectomized micefemales

    Hepatic-Specific FGF21 Knockout Abrogates Ovariectomy-Induced Obesity by Reversing Corticosterone Production

    International journal of molecular sciences

More on FGF21

Muscle mass

downin humans1

1 study
  1. Muscle mass is linked with lower insulin in humans (β = -0.40; 95% CI: -0.79, -0.01).

    “Women with low muscle mass had higher levels of insulin (uIU/mL; β = -0.40; 95% CI: -0.79, -0.01)”

    Humansfemalesn = 74

    Association of muscle mass measured by D3-Creatine (D3Cr), sarcopenic obesity, and insulin-glucose homeostasis in postmenopausal women

    PloS one

More on Muscle mass

Weight gain

upin humans1

1 study
  1. Weight gain is linked with higher insulin in humans (+24% vs -10%).

    “In 566 individuals with ≥+3% weight gain vs 561 with weight change ≤-3%, divergent patterns were observed for insulin (+24% vs -10%)”

    Humans

    Longitudinal profiling of metabolic ageing trends in two population cohorts of young adults

    International journal of epidemiology

SIRT4

downin mice1

1 study
  1. SIRT4 decreases insulin in mice (glucose-stimulated).

    “we found SIRT4KO mice consistently had elevated glucose- and leucine-stimulated insulin levels in vivo”

    Animalsglucose-stimulated

    Loss of sirtuin 4 leads to elevated glucose- and leucine-stimulated insulin levels and accelerated age-induced insulin resistance in multiple murine genetic backgrounds

    Journal of inherited metabolic disease

More on SIRT4

FOSB

downin mice1

1 study
  1. FOSB decreases insulin in mice.

    “suppresses insulin secretion”

    Animalsventral hypothalamus

    Hypothalamic ΔFosB prevents age-related metabolic decline and functions via SNS

    Aging

More on FOSB

Older age

upin humans1

1 study
  1. Older age increases insulin in humans (fed state) (50% higher than young subjects).

    “the older subjects had a 50% higher concentration than the young subjects in the fed state (p < 0.05)”

    Human trialfed stateplasma30 g whey protein30 min after protein ingestion

    Aging Reduces the Activation of the mTORC1 Pathway after Resistance Exercise and Protein Intake in Human Skeletal Muscle: Potential Role of REDD1 and Impaired Anabolic Sensitivity

    Nutrients

Associations

64

Metabolic syndrome

upin humans2OR 1.25

2 studies
  1. Insulin predicts metabolic syndrome in humans (Diagnostic classification) (AUC 0.998).

    “and an AUC of 0.998 for insulin.”

    HumansDiagnostic classificationserum

    Serum Klotho as a feasible diagnostic biomarker for metabolic syndrome in Iraqi adults aged over 50 years

    Journal of Associated Medical Sciences

  2. Insulin predicts metabolic syndrome in humans (AUC: 0.773 (0.653-0.893)).

    “AUC: 0.773 (0.653-0.893) and 0.783 by cross validation and bootstrapping samples for MetS risk”

    Humans

    Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study)

    Nutrients

  3. Insulin is linked with a higher risk of metabolic syndrome in humans (adjusted models) (OR: 1.25 (1.09-1.43)).

    “in adjusted models it was found to be associated with at least two CM risk factors and MetS risk (OR: 1.87 (1.24-2.83) and OR: 1.25 (1.09-1.43)) respectively”

    Humansadjusted models

    Diagnostic Power of Circulatory Metabolic Biomarkers as Metabolic Syndrome Risk Predictors in Community-Dwelling Older Adults in Northwest of England (A Feasibility Study)

    Nutrients

More on Metabolic syndrome

Cognitive function

downin humans2

2 studies
  1. Insulin is associated with cognitive function in humans (post-exercise in obese-IGT adults).

    “Greater insulin levels in Obese-IGT post-exercise also negatively correlated with changes in cognitive function following exercise (p < 0.01).”

    Human trialpost-exercise in obese-IGT adults

    Glucose tolerance status associates with improvements in cognitive function following high-intensity exercise in adults with obesity

    Physiology & behavior

  2. Insulin is associated with cognitive function in humans (adjusted regression analyses).

    “higher insulin and leptin levels, and lower adiponectin and receptors for advanced glycation-end products levels, respectively, were each associated with lower levels of global cognition.”

    Humansadjusted regression analyses

    Associations of Serum Insulin and Related Measures With Neuropathology and Cognition in Older Persons With and Without Diabetes

    Annals of neurology

Dietary restriction

upin humans1mixedin rats1

2 studies
  1. Dietary restriction is associated with insulin in rats.

    “Significantly changed insulin content in the hippocampus, together with altered insulin signaling were found under the influence of DR”

    Animalshippocampusmales

    Dietary restriction alters insulin signaling pathway in the brain

    BioFactors (Oxford, England)

  2. Dietary restriction predicts insulin in humans.

    “validated the changes of insulin, IGF-1 and IGFBP-1,2 to monitor DR effects”

    Review

    Effects of dietary restriction on adipose mass and biomarkers of healthy aging in human

    Aging

More on Dietary restriction

CDKN1A

upin humans1downin humans1

2 studies
  1. Insulin is associated with CDKN1A in validation cohort.

    “By using transcriptomic data from the KOBS study, we could validate the association of insulin with p21 in the liver.”

    Humansin validation cohortlivern = 180

    Hyperinsulinemia Is Highly Associated With Markers of Hepatocytic Senescence in Two Independent Cohorts

    Diabetes

  2. Insulin is associated with CDKN1A in humans (regression model) (B = -0.065, p = 0.026).

    “The p21 gene expression was inversely associated with circulating insulin (B = -0.065, p = 0.026) and C-peptide levels (unadjusted B = -0.097, p = 0.014; adjusted B = -0.133, p = 0.003).”

    Humansregression modelleucocytesn = 210

    The Relationship of Birth Size and Postnatal Growth with Cellular Senescence in Adults: Data from the New Delhi Birth Cohort

    Indian journal of pediatrics

More on CDKN1A

Metabolic dysfunction-associated steatotic liver disease

upin humans1OR 1.04

1 study
  1. Insulin predicts metabolic dysfunction-associated steatotic liver disease in humans (predicting NAFLD) (AUC 0.774, 95% CI 0.757-0.792).

    “serum insulin had good discriminative ability for predicting NAFLD, with an area under the curve of 0.774 (95% CI: 0.757-0.792)”

    Humanspredicting NAFLDn = 2,791

    Association between serum insulin levels and ultrasound-defined nonalcoholic fatty liver disease: A cross-sectional study based on NHANES 2017-2020

    Medicine

  2. Insulin is linked with a higher risk of metabolic dysfunction-associated steatotic liver disease in humans (continuous variable, adjusted for covariates) (OR 1.04, 95% CI 1.01-1.07).

    “serum insulin levels treated as a continuous variable were significantly associated with increased odds of having NAFLD (odds ratio [OR] = 1.04; 95% confidence interval [CI]: 1.01-1.07; P = .014)”

    Humanscontinuous variable, adjusted for covariatesn = 2,791

    Association between serum insulin levels and ultrasound-defined nonalcoholic fatty liver disease: A cross-sectional study based on NHANES 2017-2020

    Medicine

More on Metabolic dysfunction-associated steatotic liver disease

SHBG

downin humans1

1 study
  1. SHBG is associated with insulin in humans (β = −7.5030).

    “A significant inverse association was observed between insulin and SHBG [effect estimate (β) = −7.5030, p = 0.0010;; ].”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

  2. SHBG is associated with insulin in humans (p = 0.0010).

    “SHBG was significantly and inversely associated with insulin (p = 0.0010), insulin resistance score (HOMA-IR; p = 0.0012)”

    Human trialfemalesn = 10

    Ketosis suppression and ageing (KetoSAge): the effect of suppressing ketosis on SHBG and sex hormone profiles in healthy premenopausal women, and its implications for cancer risk and therapy

    Frontiers in nutrition

More on SHBG

Pittsburgh Sleep Quality Index

upin humans1

1 study
  1. Pittsburgh Sleep Quality Index is associated with insulin in humans (university students).

    “Insulin was positively correlated with the PSQI score”

    Humansuniversity studentsn = 243

    Sleep quality, social jet lag, and cardiovascular risk factors in young adults

    Frontiers in public health

More on Pittsburgh Sleep Quality Index

Reverse-transformed empirical dietary inflammatory index

downin humans1

1 study
  1. Reverse-transformed empirical dietary inflammatory index is associated with insulin in humans (beta -0.086 (95% CI -0.130, -0.043)).

    “insulin [-0.086 (-0.130, -0.043)]”

    Humansquantile regression at the median of each biomarker distribution, adjusted for sociodemographic and lifestyle factors1 standard deviation increment in adherencen = 1,769

    Biological signature of dietary patterns in older adults: findings from a population-based study

    BMC medicine

More on Reverse-transformed empirical dietary inflammatory index

Social jetlag

upin humans1

1 study
  1. Social jetlag is associated with insulin in humans (p < 0.05).

    “Participants with SJL had significantly higher Body Mass Index (BMI), waist and hip circumference, body fat mass (BFM), and insulin levels (p < 0.05).”

    Humansn = 223

    Relationship between genetic risk, social jetlag, and obesity traits in a Turkish adult population

    Chronobiology international

More on Social jetlag

Old age

upin E. caballus1

1 study
  1. Old age is associated with insulin in E. caballus during graded exercise test after 8 weeks of training (GXT2).

    “Young horses had lower plasma insulin concentrations than old horses during GXT2 (P = 0.005), but not during GXT1.”

    Animalsduring graded exercise test after 8 weeks of training (GXT2)plasma8 weeksfemales

    Hypothalamic-pituitary-adrenal axis response and glucose homeostasis during exercise to fatigue before and after training in old and young adult Standardbred mares

    Journal of equine veterinary science

Chenopodium quinoa-based functional formulation

mixedin humans1

1 study
  1. Chenopodium quinoa-based functional formulation is associated with insulin in humans.

    “Interaction plots revealed significant effects depending on the product consumed and the intervention period for insulin, triglycerides, APOA, and monocytes' phenotype.”

    Human trial12 days

    Healthy Improvement of Metabolic Biomarkers During an Immunonutritional Intervention: A Crossover Controlled Trial

    Molecular nutrition & food research

More on Chenopodium quinoa-based functional formulation

Change in insulin sensitivity

upin humans1

1 study
  1. Insulin is associated with change in insulin sensitivity in humans (diet-induced weight loss group, pre-intervention measure) (r = 0.60).

    “Pre-intervention measures of insulin (r = 0.60) and HOMA-IR (r = 0.56) were associated with change in insulin sensitivity (C_IS) in the WL group”

    Human trialdiet-induced weight loss group, pre-intervention measure6 months

    Individual Response Variation in the Effects of Weight Loss and Exercise on Insulin Sensitivity and Cardiometabolic Risk in Older Adults

    Frontiers in endocrinology

More on Change in insulin sensitivity

ADIPOQ

downin humans1

1 study
  1. ADIPOQ is associated with insulin in humans (GG genotype of rs1501299, after Diet P) (GG -3.2±1.0 mU/L vs GT±TT -0.6±0.4 mU/L: p=0.01).

    “After Diet P, only subjects with GG genotype showed a significant improvement in the insulin levels”

    Human trialGG genotype of rs1501299, after Diet P12 weeks

    Single nucleotide polymorphisms at the ADIPOQ gene locus rs1501299 interact with different type of dietary fatty acids in two hypocaloric diets

    European review for medical and pharmacological sciences

More on ADIPOQ

SREBF1

mixedin humans1

1 study
  1. SREBF1 is associated with insulin in humans.

    “The three tSNPs (rs12953299, rs4925118 and rs4925115) were associated with differences in the response of plasma insulin levels (p = 0.01, p = 0.005 and p = 0.004, respectively)”

    Human trial5 g/day6-weekn = 210

    SREBF1 gene variations modulate insulin sensitivity in response to a fish oil supplementation

    Lipids in health and disease

More on SREBF1

Cerebral metabolic rate of glucose

downin humans1

1 study
  1. Insulin is associated with cerebral metabolic rate of glucose in humans.

    “Higher plasma triglyceride levels and higher plasma insulin levels were associated with lower CMRg in several regions”

    Human trialbrain

    Brain and systemic glucose metabolism in the healthy elderly following fish oil supplementation

    Prostaglandins, leukotrienes, and essential fatty acids

More on Cerebral metabolic rate of glucose

All 64

Funding

182 grants since 2016

National Institute of Diabetes and Digestive and Kidney Diseases$54.4MNational Institute on Aging$43.2MNational Heart, Lung, and Blood Institute$18.2M

How this record changed

  1. Summary rewritten as its findings changed.

    As it read before

    Insulin is associated with cellular senescence in human liver and frailty in dogs. Mouse studies report decreases with caloric restriction, but increases in female TejJ89 and TejJ114 mice. Human trials report decreases with exercise in older women with sarcopenic obesity; acarbose reduces insulin in postprandial studies but shows no change in a trial in non-insulin-dependent diabetes.

  2. Summary rewritten as its findings changed.

    As it read before

    Pre-pregnancy overweight/obesity is associated with insulin at six months postpartum in a human study of women. A separate human study reports lower insulin with an anti-inflammatory diet; a review describes reductions with high-frequency exercise interruptions.

  3. Summary written from the findings.

Latest

See all 12,068 papers on insulin